These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21979798)

  • 1. Timing of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infection.
    Sturt AS; Halpern MS; Sullivan B; Maldonado YA
    Pediatr Infect Dis J; 2012 Jan; 31(1):53-60. PubMed ID: 21979798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.
    Puthanakit T; Aurpibul L; Oberdorfer P; Akarathum N; Kanjananit S; Wannarit P; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2007 Feb; 44(4):599-604. PubMed ID: 17243067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort.
    Berk DR; Falkovitz-Halpern MS; Hill DW; Albin C; Arrieta A; Bork JM; Cohan D; Nilson B; Petru A; Ruiz J; Weintrub PS; Wenman W; Maldonado YA;
    JAMA; 2005 May; 293(18):2221-31. PubMed ID: 15886377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10).
    Dollfus C; Le Chenadec J; Faye A; Blanche S; Briand N; Rouzioux C; Warszawski J
    Clin Infect Dis; 2010 Jul; 51(2):214-24. PubMed ID: 20536367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care.
    Judd A; Doerholt K; Tookey PA; Sharland M; Riordan A; Menson E; Novelli V; Lyall EG; Masters J; Tudor-Williams G; Duong T; Gibb DM; ;
    Clin Infect Dis; 2007 Oct; 45(7):918-24. PubMed ID: 17806062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort.
    Wamalwa DC; Obimbo EM; Farquhar C; Richardson BA; Mbori-Ngacha DA; Inwani I; Benki-Nugent S; John-Stewart G
    BMC Pediatr; 2010 May; 10():33. PubMed ID: 20482796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.
    Banerjee T; Pensi T; Banerjee D; Grover G
    Ann Trop Paediatr; 2010; 30(1):27-37. PubMed ID: 20196931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Jun; 46(11):1751-60. PubMed ID: 18426371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Ylitalo N; Brogly S; Hughes MD; Nachman S; Dankner W; Van Dyke R; Seage GR;
    Arch Pediatr Adolesc Med; 2006 Aug; 160(8):778-87. PubMed ID: 16894075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents.
    Eley B; Nuttall J; Davies MA; Smith L; Cowburn C; Buys H; Hussey G
    S Afr Med J; 2004 Aug; 94(8):643-6. PubMed ID: 15352588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.
    de Martino M; Tovo PA; Balducci M; Galli L; Gabiano C; Rezza G; Pezzotti P
    JAMA; 2000 Jul; 284(2):190-7. PubMed ID: 10889592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil.
    Pilotto JH; Velasque LS; Friedman RK; Moreira RI; Veloso VG; Grinsztejn B; Morgado MG; Watts DH; Currier JS; Hoffman RM
    Antivir Ther; 2011; 16(3):349-56. PubMed ID: 21555817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States.
    Melekhin VV; Shepherd BE; Jenkins CA; Stinnette SE; Rebeiro PF; Bebawy SS; Rasbach DA; Hulgan T; Sterling TR
    AIDS Patient Care STDS; 2010 May; 24(5):279-86. PubMed ID: 20438375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of antiretroviral treatment in women after delivery can induce multiclass drug resistance in breastfeeding HIV-infected infants.
    Fogel J; Li Q; Taha TE; Hoover DR; Kumwenda NI; Mofenson LM; Kumwenda JJ; Fowler MG; Thigpen MC; Eshleman SH
    Clin Infect Dis; 2011 Apr; 52(8):1069-76. PubMed ID: 21460326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality trends in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Abrams EJ; Carter RJ; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Clin Infect Dis; 2011 Nov; 53(10):1024-34. PubMed ID: 22002982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.